InMode Ltd.INMD
Health Care · Health Care Equipment & Services · NASDAQ · Israel · inmodemd.com
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Key ratios
Operating cash flow growth
-20.1%TTM
2025
-35.7%2024
-25.0%2023
-2.6%
EPS growth
-52.0%TTM
2025
-36.4%2024
-2.2%2023
21.7%
FCF / Sales
22.7%2025
2024
33.4%2023
35.8%
Net margin
20.7%TTM
2025
25.3%2024
45.9%2023
40.2%
ROA
6.2%TTM
2025
6.9%2024
8.5%2023
16.2%
ROE
12.3%TTM
2025
13.5%2024
24.3%2023
29.5%
Revenue growth
-6.2%2025
2024
-19.8%2023
8.3%
Track INMD in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer